Peptcell Limited News Today

HVIVO phase I results for Imutex's mosquito vaccine published in eBioMedicine

Investegate announcements from hVIVO PLC, Imutex Phase I data published

/PRNewswire/ -- DelveInsights Seasonal Influenza Market Insights report includes a comprehensive understanding of current treatment practices, seasonal...

The seasonal influenza market size is anticipated to increase in the coming years owing to the launch of the emerging therapies and vaccines. The current pipeline of seasonal influenza consists

Data further supports the continued development of FLU-v as a broad-spectrum influenza vaccine - News - PharmaTimes

Investegate announcements from Open Orphan PLC, Positive in vitro results for FLU-v published

Open Orphan further positive data for FLU-v

ConserV Bioscience and eTheRNA immunotherapies to Collaborate on Development of mRNA Vaccines for Infectious Diseases News provided by Share this article LONDON and NIEL, Belgium, March 4, 2021 /PRNewswire/ -- ConserV Bioscience Limited ("ConserV"), a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, and eTheRNA immunotherapies NV ("eTheRNA"), a clinical-stage immunotherapy company focused on mRNA antigen deliver...

Share this article Share this article LONDON, Jan. 19, 2021 /PRNewswire/ -- ConserV Bioscience Limited ("ConserV"), a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases and Lawrence Livermore National Laboratory ("LLNL") have agreed to collaborate on the development of a broad-spectrum coronavirus vaccine. This collaboration brings together ConserVs expertise in identifying antigens and Lawrence Livermore National ...